SCHEMBL7008952

SCHEMBL7008952

O=C1[N]c2ccccc2-c2ccccc2N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
PDGFRA P16234 1/20 0.45
FER P16591 1/20 0.45
LTK P29376 1/20 0.45
CDK8 P49336 1/20 0.45
ACVR1 Q04771 1/20 0.45
DYRK1B Q9Y463 1/20 0.45
MAPT P10636 7/20 0.44
LMNA P02545 3/20 0.44
GAA P10253 1/20 0.44
GSK3B P49841 2/20 0.43
CASP3 P42574 1/20 0.38
CASP2 P42575 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38
CASP8 Q14790 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20723 0.83 MAPT (0.44) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL20505096 0.83 MAPT (0.44) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL370447 0.79 LRRK2 (0.48) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL21296775 0.79 GSK3B (0.52) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL555451 0.79 GSK3B (0.52) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL2203198 0.72 LRRK2 (0.50) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL7980321 0.72 MAPT (0.56) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL6255304 0.71 LRRK2 (0.58) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL24062 0.69 MEN1 (0.37) MAOAMAOBMAPTLMNAGSK3B
SCHEMBL17816635 0.67 LRRK2 (0.59) LRRK2MAOAMAOBPDGFRAFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163239-B1 MODIFIED AMINO-ACID AMIDES AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-28 EP claimed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US claimed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US disclosed